• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用可解释集成人工智能模型对日本全国真实世界数据中血液透析患者和治疗进行分类。

Application of explainable ensemble artificial intelligence model to categorization of hemodialysis-patient and treatment using nationwide-real-world data in Japan.

机构信息

Medical Science, Kawasaki Medical School, Kurashiki, Okayama, Japan.

College of Engineering, University of Michigan, Ann Arbor, Michigan, United States of America.

出版信息

PLoS One. 2020 May 29;15(5):e0233491. doi: 10.1371/journal.pone.0233491. eCollection 2020.

DOI:10.1371/journal.pone.0233491
PMID:32469924
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7259704/
Abstract

BACKGROUND

Although dialysis patients are at a high risk of death, it is difficult for medical practitioners to simultaneously evaluate many inter-related risk factors. In this study, we evaluated the characteristics of hemodialysis patients using machine learning model, and its usefulness for screening hemodialysis patients at a high risk of one-year death using the nation-wide database of the Japanese Society for Dialysis Therapy.

MATERIALS AND METHODS

The patients were separated into two datasets (n = 39,930, 39,930, respectively). We categorized hemodialysis patients in Japan into new clusters generated by the K-means clustering method using the development dataset. The association between a cluster and the risk of death was evaluated using multivariate Cox proportional hazards models. Then, we developed an ensemble model composed of the clusters and support vector machine models in the model development phase, and compared the accuracy of the prediction of mortality between the machine learning models in the model validation phase.

RESULTS

Average age of the subjects was 65.7±12.2 years; 32.7% had diabetes mellitus. The five clusters clearly distinguished the groups on the basis of their characteristics: Cluster 1, young male, and chronic glomerulonephritis; Cluster 2, female, and chronic glomerulonephritis; Cluster 3, diabetes mellitus; Cluster 4, elderly and nephrosclerosis; Cluster 5, elderly and protein energy wasting. These clusters were associated with the risk of death; Cluster 5 compared with Cluster 1, hazard ratio 8.86 (95% CI 7.68, 10.21). The accuracy of the ensemble model for the prediction of 1-year death was 0.948 and higher than those of logistic regression model (0.938), support vector machine model (0.937), and deep learning model (0.936).

CONCLUSIONS

The clusters clearly categorized patient on their characteristics, and reflected their prognosis. Our real-world-data-based machine learning system is applicable to identifying high-risk hemodialysis patients in clinical settings, and has a strong potential to guide treatments and improve their prognosis.

摘要

背景

尽管透析患者的死亡风险较高,但临床医生很难同时评估许多相互关联的风险因素。在这项研究中,我们使用机器学习模型评估了血液透析患者的特征,并利用日本透析治疗学会的全国性数据库评估了该模型筛选血液透析患者一年死亡风险的效用。

材料和方法

将患者分为两个数据集(n = 39930,n = 39930)。我们使用开发数据集的 K 均值聚类方法将日本血液透析患者分为新的聚类。使用多变量 Cox 比例风险模型评估聚类与死亡风险之间的关联。然后,在模型开发阶段,我们构建了一个由聚类和支持向量机模型组成的集成模型,并在模型验证阶段比较了这些机器学习模型预测死亡率的准确性。

结果

研究对象的平均年龄为 65.7±12.2 岁,32.7%患有糖尿病。这 5 个聚类可以根据其特征清楚地区分不同的组别:聚类 1,年轻男性,慢性肾小球肾炎;聚类 2,女性,慢性肾小球肾炎;聚类 3,糖尿病;聚类 4,老年,肾动脉硬化;聚类 5,老年,蛋白质能量消耗不良。这些聚类与死亡风险相关;与聚类 1 相比,聚类 5 的危险比为 8.86(95%可信区间为 7.68,10.21)。该集成模型预测 1 年死亡率的准确性为 0.948,高于逻辑回归模型(0.938)、支持向量机模型(0.937)和深度学习模型(0.936)。

结论

这些聚类可以清楚地对患者的特征进行分类,并反映其预后。我们基于真实世界数据的机器学习系统适用于识别临床环境中的高风险血液透析患者,具有指导治疗和改善预后的强大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/7259704/cc302f7b1853/pone.0233491.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/7259704/54bdbf6c6bb4/pone.0233491.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/7259704/ecbd729fab37/pone.0233491.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/7259704/7b8848b9f909/pone.0233491.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/7259704/30fa0b210a54/pone.0233491.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/7259704/fd62950cdcf4/pone.0233491.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/7259704/7f8bcfe86511/pone.0233491.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/7259704/c89ba06d1e5d/pone.0233491.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/7259704/007cf2228f29/pone.0233491.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/7259704/7383851873ef/pone.0233491.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/7259704/2c73bfc2d0e6/pone.0233491.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/7259704/6374fe4d0ed2/pone.0233491.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/7259704/cc302f7b1853/pone.0233491.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/7259704/54bdbf6c6bb4/pone.0233491.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/7259704/ecbd729fab37/pone.0233491.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/7259704/7b8848b9f909/pone.0233491.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/7259704/30fa0b210a54/pone.0233491.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/7259704/fd62950cdcf4/pone.0233491.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/7259704/7f8bcfe86511/pone.0233491.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/7259704/c89ba06d1e5d/pone.0233491.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/7259704/007cf2228f29/pone.0233491.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/7259704/7383851873ef/pone.0233491.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/7259704/2c73bfc2d0e6/pone.0233491.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/7259704/6374fe4d0ed2/pone.0233491.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/7259704/cc302f7b1853/pone.0233491.g012.jpg

相似文献

1
Application of explainable ensemble artificial intelligence model to categorization of hemodialysis-patient and treatment using nationwide-real-world data in Japan.应用可解释集成人工智能模型对日本全国真实世界数据中血液透析患者和治疗进行分类。
PLoS One. 2020 May 29;15(5):e0233491. doi: 10.1371/journal.pone.0233491. eCollection 2020.
2
Use of vasopressor for dialysis-related hypotension is a risk factor for death in hemodialysis patients: Nationwide cohort study.血管加压素用于透析相关低血压是血液透析患者死亡的一个危险因素:全国队列研究。
Sci Rep. 2019 Mar 4;9(1):3362. doi: 10.1038/s41598-019-39908-6.
3
[The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].[威尼托地区透析与移植登记处:2006 - 2007年报告]
G Ital Nefrol. 2009 Nov-Dec;26 Suppl 48:S5-56.
4
Effect of dialyzer membrane materials on survival in chronic hemodialysis patients: Results from the annual survey of the Japanese Nationwide Dialysis Registry.透析器膜材料对慢性血液透析患者生存的影响:日本全国透析登记年度调查结果
PLoS One. 2017 Sep 14;12(9):e0184424. doi: 10.1371/journal.pone.0184424. eCollection 2017.
5
Construction data mining methods in the prediction of death in hemodialysis patients using support vector machine, neural network, logistic regression and decision tree.使用支持向量机、神经网络、逻辑回归和决策树进行血液透析患者死亡预测的构建数据挖掘方法。
J Prev Med Hyg. 2021 Apr 29;62(1):E222-E230. doi: 10.15167/2421-4248/jpmh2021.62.1.1837. eCollection 2021 Mar.
6
Development of a prognostic risk score to predict early mortality in incident elderly Japanese hemodialysis patients.建立预测日本老年血液透析患者早期死亡率的预后风险评分模型。
PLoS One. 2024 Apr 11;19(4):e0302101. doi: 10.1371/journal.pone.0302101. eCollection 2024.
7
Study on Dialysis Session Length and Mortality in Maintenance Hemodialysis Patients: The Q-Cohort Study.维持性血液透析患者透析时间与死亡率的研究:Q 队列研究。
Nephron. 2018;139(4):305-312. doi: 10.1159/000489680. Epub 2018 Jun 7.
8
The Different Association between Serum Ferritin and Mortality in Hemodialysis and Peritoneal Dialysis Patients Using Japanese Nationwide Dialysis Registry.利用日本全国透析登记系统研究血液透析和腹膜透析患者血清铁蛋白与死亡率之间的不同关联
PLoS One. 2015 Nov 23;10(11):e0143430. doi: 10.1371/journal.pone.0143430. eCollection 2015.
9
High-Performance Membrane Dialyzers and Mortality in Hemodialysis Patients: A 2-Year Cohort Study from the Annual Survey of the Japanese Renal Data Registry.高性能膜透析器与血液透析患者死亡率:来自日本肾脏数据登记年度调查的一项为期2年的队列研究
Am J Nephrol. 2017;46(1):82-92. doi: 10.1159/000478032. Epub 2017 Jul 4.
10
Dialysis fluid endotoxin level and mortality in maintenance hemodialysis: a nationwide cohort study.维持性血液透析患者透析液内毒素水平与死亡率:一项全国性队列研究。
Am J Kidney Dis. 2015 Jun;65(6):899-904. doi: 10.1053/j.ajkd.2014.12.009. Epub 2015 Jan 30.

引用本文的文献

1
Development of Artificial Intelligence Systems for Chronic Kidney Disease.慢性肾脏病人工智能系统的开发
JMA J. 2025 Jan 15;8(1):48-56. doi: 10.31662/jmaj.2024-0090. Epub 2024 Sep 6.
2
Machine learning approaches for predicting and diagnosing chronic kidney disease: current trends, challenges, solutions, and future directions.用于预测和诊断慢性肾脏病的机器学习方法:当前趋势、挑战、解决方案及未来方向。
Int Urol Nephrol. 2025 Apr;57(4):1245-1268. doi: 10.1007/s11255-024-04281-5. Epub 2024 Nov 19.
3
Coronary Artery Disease in Patients Undergoing Hemodialysis: A Problem that Sounds the Alarm.

本文引用的文献

1
Machine Learning to Identify Dialysis Patients at High Death Risk.利用机器学习识别高死亡风险的透析患者。
Kidney Int Rep. 2019 Jun 22;4(9):1219-1229. doi: 10.1016/j.ekir.2019.06.009. eCollection 2019 Sep.
2
A machine learning-based approach for predicting the outbreak of cardiovascular diseases in patients on dialysis.基于机器学习的方法预测透析患者心血管疾病的爆发。
Comput Methods Programs Biomed. 2019 Aug;177:9-15. doi: 10.1016/j.cmpb.2019.05.005. Epub 2019 May 13.
3
A new nutritional risk index for predicting mortality in hemodialysis patients: Nationwide cohort study.
接受血液透析患者的冠状动脉疾病:一个敲响警钟的问题。
Rev Cardiovasc Med. 2024 May 30;25(6):200. doi: 10.31083/j.rcm2506200. eCollection 2024 Jun.
4
Predict, diagnose, and treat chronic kidney disease with machine learning: a systematic literature review.利用机器学习预测、诊断和治疗慢性肾脏病:系统文献回顾。
J Nephrol. 2023 May;36(4):1101-1117. doi: 10.1007/s40620-023-01573-4. Epub 2023 Feb 14.
5
Machine Learning for Renal Pathologies: An Updated Survey.机器学习在肾病变中的应用:最新研究综述。
Sensors (Basel). 2022 Jul 1;22(13):4989. doi: 10.3390/s22134989.
6
Application of a Remotely Controlled Artificial Intelligence Analgesic Pump Device in Painless Treatment of Children.远程控制人工智能镇痛泵装置在儿童无痛治疗中的应用。
Contrast Media Mol Imaging. 2022 Apr 6;2022:1013241. doi: 10.1155/2022/1013241. eCollection 2022.
一种新的营养风险指数,用于预测血液透析患者的死亡率:全国队列研究。
PLoS One. 2019 Mar 28;14(3):e0214524. doi: 10.1371/journal.pone.0214524. eCollection 2019.
4
Use of vasopressor for dialysis-related hypotension is a risk factor for death in hemodialysis patients: Nationwide cohort study.血管加压素用于透析相关低血压是血液透析患者死亡的一个危险因素:全国队列研究。
Sci Rep. 2019 Mar 4;9(1):3362. doi: 10.1038/s41598-019-39908-6.
5
US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States.美国肾脏数据系统2018年年报:美国肾脏疾病流行病学
Am J Kidney Dis. 2019 Mar;73(3 Suppl 1):A7-A8. doi: 10.1053/j.ajkd.2019.01.001. Epub 2019 Feb 21.
6
High-performance medicine: the convergence of human and artificial intelligence.高性能医学:人机智能融合。
Nat Med. 2019 Jan;25(1):44-56. doi: 10.1038/s41591-018-0300-7. Epub 2019 Jan 7.
7
The practical implementation of artificial intelligence technologies in medicine.人工智能技术在医学中的实际应用。
Nat Med. 2019 Jan;25(1):30-36. doi: 10.1038/s41591-018-0307-0. Epub 2019 Jan 7.
8
A systematic review of the clinical application of data-driven population segmentation analysis.数据驱动的人群细分分析在临床应用中的系统评价。
BMC Med Res Methodol. 2018 Nov 3;18(1):121. doi: 10.1186/s12874-018-0584-9.
9
Cardiovascular disease in dialysis patients.透析患者的心血管疾病。
Nephrol Dial Transplant. 2018 Oct 1;33(suppl_3):iii28-iii34. doi: 10.1093/ndt/gfy174.
10
Assessing the validity of a data driven segmentation approach: A 4 year longitudinal study of healthcare utilization and mortality.评估数据驱动分割方法的有效性:一项针对医疗利用和死亡率的 4 年纵向研究。
PLoS One. 2018 Apr 5;13(4):e0195243. doi: 10.1371/journal.pone.0195243. eCollection 2018.